Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

PCOS should be reclassified into two types based on hormone levels and symptoms.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Overweight women with PCOS are more likely to have excess male hormones.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The questionnaire is valid and reliable but needs more testing for future predictions.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

AMH is a promising biomarker for diagnosing PCOS.

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.